<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is a benign condition causing <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, which is also a symptom of liver or <z:e sem="disease" ids="C1263988" disease_type="Disease or Syndrome" abbrv="">hemolytic disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A genetic test may be possible for <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> because an associated gene defect has been isolated </plain></SENT>
<SENT sid="2" pm="."><plain>Here we present a mathematical analysis of the use of this test in excluding harmful causes of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The effectiveness of the test depends on a low prevalence and high penetrance of the gene defect and a low prevalence of harmful <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>If the gene defect has a 12% prevalence and 10% penetrance, then the prevalence of harmful <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> needs to be &lt;1.5% for a positive test to reduce this risk fivefold </plain></SENT>
<SENT sid="5" pm="."><plain>Estimates of the prevalence of harmful <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> and of the prevalence and penetrance of the Gilbert genotype are required to assess the value of the genetic test in determining a cause of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Until these values for prevalence and penetrance are known, genetic testing for <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> cannot be recommended on a routine basis </plain></SENT>
</text></document>